TrialOrphanet journal of rare diseases2023

A post hoc analysis of Projected Retained Ability Scores (PRAS) for the longitudinal assessment of cognitive functioning in patients with neuronopathic mucopolysaccharidosis II receiving intrathecal idursulfase-IT.

Karen S Yee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.